These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 391240

  • 1. Effect of p-hydroxyphenyl-propionic ester of tranexamic acid hydrochloride (Cetraxate) on peptic ulcer. Multi-center clinical study.
    Ishimori A, Yamagata S, Taima T.
    Arzneimittelforschung; 1979; 29(10):1625-32. PubMed ID: 391240
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic effect of pirenzepine dihydrochloride on gastric ulcer evaluated by a double-blind controlled clinical study. Phase III study.
    Ishimori A, Yamagata S.
    Arzneimittelforschung; 1982; 32(5):556-65. PubMed ID: 7049190
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effects of cetraxate against acute gastritis and acute aggravation of chronic gastritis. Endoscopic investigation by the double-blind method.
    Yamagata S, Miura K.
    Arzneimittelforschung; 1983; 33(8):1191-5. PubMed ID: 6357203
    [Abstract] [Full Text] [Related]

  • 4. Cetraxate is not superior to placebo in the treatment of duodenal ulcer.
    Bianchi Porro G, Ardizzone S, Petrillo M.
    J Clin Gastroenterol; 1990 Apr; 12(2):234-6. PubMed ID: 2182708
    [No Abstract] [Full Text] [Related]

  • 5. Cetraxate and antacid in the treatment of gastric ulcer. A controlled clinical trial.
    Wilairatana S, Kladchareon N, Kositsurunkakul S, Israsena S.
    J Med Assoc Thai; 1985 Jul; 68(7):333-41. PubMed ID: 3903020
    [No Abstract] [Full Text] [Related]

  • 6. [Cetraxate in duodenal ulcer, a double-blind clinical study (author's transl)].
    Yu JY, Wang TH, Wang CY, Chen RR, Sung JL.
    Taiwan Yi Xue Hui Za Zhi; 1981 Apr; 80(4):442-8. PubMed ID: 7031178
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of alprazolam, gefarnate and their combination in treatment of peptic ulcer patients--an application of life table analysis.
    Ogawa N, Namiki M, Kusunoki T, Fujii S.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):109-11. PubMed ID: 2859256
    [Abstract] [Full Text] [Related]

  • 8. Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study.
    Laurberg G.
    Acta Derm Venereol; 1977 Feb; 57(4):369-70. PubMed ID: 70935
    [Abstract] [Full Text] [Related]

  • 9. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; synergistic drugs for protective factors in peptic ulcer].
    Miyake T.
    Nihon Rinsho; 1988 Jan; 46(1):79-83. PubMed ID: 3373760
    [No Abstract] [Full Text] [Related]

  • 10. Comparative study of cimetidine and cetraxate in the treatment of peptic ulcer.
    Archimandritis A, Tjivras M, Alexiou A, Bougas S, Fertakis A.
    J Clin Gastroenterol; 1991 Feb; 13(1):114-5. PubMed ID: 2007733
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of hypermenorrhea with tranexamic acid].
    Petersen K, Jelert H, Diernaes E, Detlefsen GU.
    Ugeskr Laeger; 1983 Sep 05; 145(36):2759-60. PubMed ID: 6356545
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A.
    Spine (Phila Pa 1976); 2008 Nov 15; 33(24):2577-80. PubMed ID: 19011538
    [Abstract] [Full Text] [Related]

  • 13. [Cyklokapron (tranexamic acid) in the treatment of patients with advanced neoplasms].
    Fosså SD, Solheim O, Fosså J.
    Tidsskr Nor Laegeforen; 1978 Oct 10; 98(28):1368-70. PubMed ID: 360480
    [No Abstract] [Full Text] [Related]

  • 14. Are gastroprotective drugs useful for gastric ulcer healing: re-evaluation using current ICH E9 guidelines.
    Higuchi K, Watanabe T, Tanigawa T, Shiba M, Tominaga K, Fujiwara Y, Oshitani N, Arakawa T.
    Inflammopharmacology; 2007 Feb 10; 15(1):18-21. PubMed ID: 17323190
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN, Hahm JS, Kim HJ.
    Eur J Gastroenterol Hepatol; 1994 Dec 10; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [Abstract] [Full Text] [Related]

  • 16. [Result of an antifibrinolytic treatment using tranexamic acid for the reduction of blood-loss during and after tonsillectomy].
    Castelli G, Vogt E.
    Schweiz Med Wochenschr; 1977 Jun 04; 107(22):780-4. PubMed ID: 877527
    [Abstract] [Full Text] [Related]

  • 17. [Controlled clinical study of tranexamic acid in the treatment of inflammatory otorhinolaryngological diseases].
    Magri M.
    Clin Ter; 1981 Feb 15; 96(3):251-61. PubMed ID: 7030581
    [No Abstract] [Full Text] [Related]

  • 18. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.
    Eur J Cardiothorac Surg; 2009 Aug 15; 36(2):322-9. PubMed ID: 19250838
    [Abstract] [Full Text] [Related]

  • 19. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods].
    Fukuchi S.
    Nihon Rinsho; 1988 Jan 15; 46(1):119-23. PubMed ID: 3373744
    [No Abstract] [Full Text] [Related]

  • 20. [Endoscopic hemostasis in hemorrhagic peptic ulcer. A review and pilot study of local thrombin injection combined with systemic fibrinolysis inhibition (with tranexamic acid)].
    Stallemo A, Bang C, Børkje B, Hausken T, Pedersen R, Odegaard S, Berstad A.
    Tidsskr Nor Laegeforen; 1990 Feb 10; 110(4):497-500. PubMed ID: 2408191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.